It must be noted that the schemes were performed on TMAs with 1 or 3 cores per case, and might not completely reflect the entire tumor microenvironment or PD-L1 expression on the invasive tumor front seen in routine practice [41]. The gene discussed is CD274; the disease is neoplasm.